Cite
HARVARD Citation
Kwakman, J. et al. (2017). Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients. Acta oncologica. pp. 1023-1026. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kwakman, J. et al. (2017). Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients. Acta oncologica. pp. 1023-1026. [Online].